Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

NCT02343406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Depatuxizumab mafodotin
DRUG: Temozolomide
DRUG: Lomustine

Sponsor

AbbVie

Collaborators

[object Object]